(Q44650648)

5 December 2017

title

Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome (English)

1 reference

5 December 2017

Atomoxetine Hydrochloride: Clinical Drug-Drug Interaction Prediction and Outcome (English)

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

31 March 2024

1 reference

0 references

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

31 March 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

31 March 2024

author name string

John-Michael Sauer

1

1 reference

5 December 2017

Barbara Ring

3

1 reference

5 December 2017

David Petullo

7

1 reference

5 December 2017

Amanda J. Long

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Jennifer S. Gillespie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Nathan P. Sanburn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Karl A. DeSante

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Mark R. VandenBranden

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Charles B. Jensen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Steven A. Wrighton

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Brian P. Smith

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Holly A. Read

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

Jennifer W. Witcher

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610241

31 March 2024

language of work or name

English

0 references

publication date

10 November 2003

1 reference

full work available at URL

5 December 2017

https://syndication.highwire.org/content/doi/10.1124/jpet.103.058727

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Journal of Pharmacology and Experimental Therapeutics

31 March 2024

published in

1 reference

5 December 2017

volume

308

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

410-418

1 reference

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins)

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjects.

31 March 2024

7

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver

31 March 2024

10

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Protein measurement with the Folin phenol reagent

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Identification of the human cytochromes P450 responsible for atomoxetine metabolism

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects

31 March 2024

18

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

31 March 2024

19

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Use of human hepatocytes to study P450 gene induction

31 March 2024

20

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine.

31 March 2024

25

1 reference

https://api.crossref.org/works/10.1124/JPET.103.058727

31 March 2024

Identifiers

1 reference

5 December 2017

1 reference